ENOV Enovis Corporation
$21.16▲ +0.38%
Healthcare
Other
Volume 898.0K
Avg Volume (10D) 1.25M
Key Metrics & Fundamentals
Market Cap
$1.22B
P/E Ratio
–
Div Yield
0.00%
52W Range
16.70 - 33.13
% vs 50 MA
4.01%
% vs 200 MA
-8.68%
RSI-14
61.3
MACD Histogram
+0.4600
Beta (1Y vs SPY)
1.37
Free Cash Flow
$31.14M
Gross Rev
$582.78M
Gross Profit
$359.25M
EBITDA
$91.39M
COGS
$223.53M
Operating Exp
$336.98M
Operating Income
$22.27M
EBIT
$22.27M
Pretax Income
$7.47M
Net Income
-$1.19M
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News
Enovis (ENOV) Stock May Be 39% Undervalued On Cash Flow
Simply Wall St. · Oct 24, 2026 5:10 AM ET
1 value stock worth investigating and 2 we question
StockStory · Oct 23, 2026 2:16 PM ET
PRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy Month
GlobeNewswire · Oct 22, 2026 12:17 PM ET
1 Unprofitable Stock on Our Buy List and 2 We Turn Down
StockStory · Oct 21, 2026 11:26 AM ET
2 Stocks Under $50 Worth Your Attention and 1 We Turn Down
StockStory · Oct 15, 2026 7:12 AM ET
3 Healthcare Stocks We Find Risky
StockStory · Oct 13, 2026 6:11 AM ET
Needham Cuts Price Target on Enovis to $34 From $52, Keeps Buy Rating
MT Newswires · Oct 12, 2026 7:54 AM ET
Enovis (ENOV), Why Is Fresh Attention Building Now?
Simply Wall St. · Oct 10, 2026 7:12 AM ET
Is Enovis (ENOV) Stock Cheap After Reaffirming 2026 Guidance?
Simply Wall St. · Oct 10, 2026 1:14 AM ET
1 of Wall Street’s Favorite Stocks with Solid Fundamentals and 2 We Avoid
StockStory · Oct 8, 2026 8:32 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ENOV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.